Cargando…

MPC-02 REVIEW OF MEDULLOBLASTOMA FOR THE ASSESSMENT OF CONSENSUS IN PATHOLOGICAL DIAGNOSIS USING JPMNG CASES

Medulloblastoma (MB) is now classified by WHO 2016 classification as “genetically defined” and “histologically defined” variants. The aim of this study is to search for consensus on pathological diagnosis and assess the correlation between the central pathological diagnosis and the molecular subgrou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sasaki, Atsushi, Hirato, Jyunko, Inoue, Takeshi, Kanemura, Yonehiro, Kodama, Yoshinori, Ichimura, Koichi, Sakamoto, Hiroaki, Nishikawa, Ryo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213207/ http://dx.doi.org/10.1093/noajnl/vdz039.099

Ejemplares similares

MBRS-38. MOLECULAR CLASSIFICATION AND CLINICAL CHARACTERISTICS OF 236 MEDULLOBLASTOMAS IN JAPAN
por: Kanemura, Yonehiro, et al.
Publicado: (2020)

MPC-6 Clinical significance of whole chromosomal aberration signatures in non-metastatic medulloblastomas treated with 18Gy of craniospinal irradiation
por: Fukuoka, Kohei, et al.
Publicado: (2021)

MPC-02 Prognostic effects of molecular factors in elderly patients with IDH-wildtype Glioblastomas
por: Fukai, Junya, et al.
Publicado: (2020)

PATH-28. MOLECULAR DIAGNOSIS FOR CENTRAL DIAGNOSIS OF BRAIN TUMORS FROM 2016 TO 2019— A REPORT FROM THE JAPAN CHILDREN’S CANCER GROUP (JCCG)
por: Nakano, Yoshiko, et al.
Publicado: (2020)

MPC-04 MOLECULAR FEATURES AND CLINICAL OUTCOMES OF ELDERLY GLIOBLASTOMA PATIENTS: ANALYSES OF KANSAI NETWORK AND TCGA COHORTS
por: Fukai, Junya, et al.
Publicado: (2019)

Molecular Classification of Medulloblastoma
por: KIJIMA, Noriyuki, et al.
Publicado: (2016)

Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study
por: Fukuoka, Kohei, et al.
Publicado: (2023)

MPC-1 DNA methylome analysis suggested the presence of “true” IDH-wildtype lower-grade gliomas
por: Satomi, Kaishi, et al.
Publicado: (2021)

Slow-growing WNT medulloblastoma with atypical magnetic resonance imaging findings: illustrative case
por: Mizushima, Makoto, et al.
Publicado: (2023)

GCT-72. ANALYSIS OF microRNA EXPRESSION PROFILE OF INTRACRANIAL GERM CELL TUMORS: A PROMISING TOOL FOR DIFFERENTIAL DIAGNOSIS
por: Nakano, Yoshiko, et al.
Publicado: (2020)

MPC-08 Molecular risk stratification using genome-wide DNA methylation data of standard-risk medulloblastomas treated with 18-Gy craniospinal irradiation
por: Irikura, Tomoya, et al.
Publicado: (2020)

Distributed MPC of vehicle platoons with guaranteed consensus and string stability
por: Feng, Yangyang, et al.
Publicado: (2023)

NI-02 THE ASSOCIATION BETWEEN (11)C-METHIONINE UPTAKE, IDH GENE MUTATION, AND MGMT PROMOTER METHYLATION IN PATIENTS WITH GRADE II AND III GLIOMAS
por: Okita, Yoshiko, et al.
Publicado: (2019)

MPC-08 CLINICOPATHOLOGICAL ANALYSIS OF 12P GAIN IN INTRACRANIAL GERM CELL TUMORS
por: Satomi, Kaishi, et al.
Publicado: (2019)

MEDB-30. Subclassification of Group 3/4 medulloblastoma as a potential prognostic biomarker to reduce the dose of craniospinal irradiation in patients with metastatic tumors: A Japanese Pediatric Molecular Neuro-Oncology Group study
por: Fukuoka, Kohei, et al.
Publicado: (2022)

MPC-5 Characteristics of H3 G34-mutant gliomas
por: Kibe, Yuji, et al.
Publicado: (2021)

MPC construction techniques
Publicado: (1971)

MPC-11 IDH1/2 MUTATIONS ARE ASSOCIATED WITH SEIZURE ONSET AND VETRY IMAGING IN PATIENTS WITH DIFFUSE GLIOMA VISUALIZING 2-HYDROXYGLUTARATE BY MASS SPECTRUM
por: Ohno, Makoto, et al.
Publicado: (2019)

Activated leukocyte cell adhesion molecule expression correlates with the WNT subgroup in medulloblastoma and is involved in regulating tumor cell proliferation and invasion
por: Achiha, Takamune, et al.
Publicado: (2020)

Prenatal diagnosis of L1CAM gene mutations in X-linked hydrocephalus
por: Yamasaki, Mami, et al.
Publicado: (2006)

MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
por: Li, Xiaoli, et al.
Publicado: (2016)

Efficacy of temozolomide and bevacizumab for the treatment of leptomeningeal dissemination of recurrent glioblastoma: A case report
por: OKITA, YOSHIKO, et al.
Publicado: (2015)

Molecular subgroups of medulloblastoma: the current consensus
por: Taylor, Michael D., et al.
Publicado: (2011)

Metabolism-based targeting of MYC via MPC-SOD2 axis-mediated oxidation promotes cellular differentiation in group 3 medulloblastoma
por: Martell, Emma, et al.
Publicado: (2023)

MPC-10 Prognostic analysis in IDH mutant astrocytoma patient with CDKN2A/B homozygous deletion
por: Yanagisawa, Shunsuke, et al.
Publicado: (2021)

ATRT-02. AN INFANTILE PINEAL EMBRYONAL TUMOR SHOWING PATHOLOGICAL FEATURES OF A CNS GANGLIONEUROBLASTOMA IN ADDITION TO SMARCA4 MUTATIONS AND THE METHYLATION PROFILING OF AN ATYPICAL TERATOID/RHABDOID TUMOR
por: Fukuoka, Kohei, et al.
Publicado: (2023)

IMMU-02. Targeted innovative antibody fragment-based immunotherapy for medulloblastoma
por: Niesen, Judith, et al.
Publicado: (2022)

MPC850 integrated communications microprocessor : user's manual.
Publicado: (1998)

MPC-20 CLINICAL AND MOLECULAR FEATURES OF GLIOBLASTOMAS ARISING IN THE SETTING OF LI FRAUMENI SYNDROME
por: Kibe, Yuji, et al.
Publicado: (2022)

MPC-04 Utility of comprehensive cancer genome analysis for brain tumors
por: Miwa, Kazuhiro, et al.
Publicado: (2020)

Metaplectic representation, MPC structures and geometric quantization
por: Rawnsley, JH, et al.
Publicado: (1989)

MBRS-02. BET BROMODOMAIN PROTEIN-KINASE INHIBITOR COMBINATIONS FOR THE TREATMENT OF MEDULLOBLASTOMA
por: Ayad, Nagi, et al.
Publicado: (2020)

C-Terminal Binding Protein 1 Modulates Cellular Redox via Feedback Regulation of MPC1 and MPC2 in Melanoma Cells
por: Deng, Yu, et al.
Publicado: (2018)

Long‐term experience of MPC across multiple TrueBeam linacs: MPC concordance with conventional QC and sensitivity to real‐world faults
por: Pearson, Michael, et al.
Publicado: (2020)

Molecular Biology of Pediatric Hydrocephalus and Hydrocephalus-related Diseases
por: YAMASAKI, Mami, et al.
Publicado: (2015)

Decomposition–Coordination of Double-Layer MPC for Constrained Systems
por: Wang, Hongrui, et al.
Publicado: (2022)

NI-13 The effectiveness and limitation of survival prediction in primary glioblastoma using machine learning-based texture analysis
por: Umehara, Toru, et al.
Publicado: (2020)

Still divergent but on the way to convergence: clinical practice of CNS germ cell tumors in Europe and North America from the perspectives of the East
por: Takami, Hirokazu, et al.
Publicado: (2022)

ET-02 EFFICACY OF THE SALVAGE THERAPY VIA LOMUSTINE AND NIMUSTINE FOR RECURRENT GLIOBLASTOMA WITH TEMOZOLOMIDE RESISTANCE
por: Yamamuro, Shun, et al.
Publicado: (2019)

Nonlinear observer output-feedback MPC treatment scheduling for HIV
por: Zurakowski, Ryan
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3ockvs8hfmuffhc37kg9plbv21